GO:0015931 nucleobase-containing compound transport: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015931 nucleobase-containing compound transport describes the directed movement of nucleobases, nucleosides, nucleotides and nucleic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
• This process is essential for nucleotide homeostasis, nucleic acid metabolism, and cellular energy balance, and its disruption is linked to cancer, neurological disorders, and metabolic diseases [1,3,4].
• Key genes include SLC family transporters (e.g., SLC29A1, SLC28A1), ABC transporters (e.g., ABCC4), and nucleoside kinases that feed into transport pathways [1,3].
• Differential expression and methylation of transport-related genes have been observed in gastrointestinal tumors and delayed cerebral ischemia, highlighting their clinical relevance [1,4].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal interrogation of transport genes in disease contexts.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate research on nucleobase-containing compound transport.
Description
Nucleobase-containing compound transport (GO:0015931) is a fundamental biological process that governs the movement of nucleobases, nucleosides, nucleotides, and nucleic acids across cellular membranes and within cellular compartments. This process is mediated by specialized transporters, channels, and pores that ensure proper nucleotide availability for DNA and RNA synthesis, energy transfer, and signaling. Dysregulation of nucleobase-containing compound transport has been implicated in a wide range of pathologies, including cancer, where altered nucleoside transporter expression affects drug uptake and tumor progression [1,3]. In neurological disorders, disrupted adenosine metabolism and transport contribute to hippocampal dysfunction and delayed cerebral ischemia [4,5]. Understanding the molecular players and regulatory mechanisms of this process is therefore critical for both basic biology and therapeutic development. Recent transcriptomic and functional genomic studies have identified core genes and pathways involved in nucleobase-containing compound transport, providing a foundation for targeted experimental models [1,4,7].
nucleobase-containing compound transport At A Glance
| GO ID | GO:0015931 |
|---|---|
| GO term | nucleobase-containing compound transport |
| Ontology | biological_process |
| Synonym | nucleobase, nucleoside, nucleotide and nucleic acid transport |
| Major function | Mediates the directed movement of nucleobases, nucleosides, nucleotides and nucleic acids across membranes or within cells via transporters or pores |
| Related processes | Nucleotide metabolism, nucleic acid synthesis, adenosine signaling, drug transport |
| Cellular locations | Plasma membrane, mitochondrial membrane, nuclear envelope, endomembranes |
| Representative genes | SLC29A1, SLC28A1, ABCC4, ADK, ENTPD1 |
| Disease associations | Cancer, delayed cerebral ischemia, neurological disorders, metabolic diseases |
What Is GO:0015931?
GO:0015931 nucleobase-containing compound transport is defined as the directed movement of nucleobases, nucleosides, nucleotides, and nucleic acids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This encompasses both membrane transport and intracellular trafficking of these molecules, which are essential for nucleic acid metabolism, energy homeostasis, and cellular signaling.
Why Is nucleobase-containing compound transport Important in Cell Biology?
Nucleobase-containing compound transport is vital for maintaining cellular nucleotide pools, which are required for DNA replication, RNA transcription, and energy transfer. Disruptions in this process can lead to impaired nucleic acid synthesis, altered drug sensitivity, and disease progression [1,3]. For example, upregulation of nucleoside transporters in tumors can affect the efficacy of nucleoside analog drugs, while altered adenosine transport in the brain contributes to ischemic injury [4,5]. Therefore, studying this process is essential for understanding disease mechanisms and developing targeted therapies.
• Maintains nucleotide homeostasis for DNA and RNA synthesis.
• Regulates cellular energy balance via adenosine transport and metabolism.
• Influences drug uptake and resistance in cancer chemotherapy [1,3].
• Plays a role in neurological disorders such as delayed cerebral ischemia.
• Involved in gastrointestinal tumor diagnosis as a core gene network.
• Modulates immune responses through extracellular nucleotide signaling.
• Affects platelet function and tumor-educated platelet diagnostics.
• Provides targets for CRISPR-based functional genomics.
• Links to metabolic reprogramming in cancer and other diseases.
• Essential for normal brain development and network stabilization.
What Happens During nucleobase-containing compound transport?
Substrate recognition and binding
In simple terms: Transporters recognize specific nucleobases, nucleosides, or nucleotides and bind them for transport.
The process begins with the recognition of substrates such as adenosine, guanosine, or nucleotide analogs by specific transporters or pores. For instance, SLC29A1 (ENT1) binds adenosine and nucleoside analogs with high affinity, facilitating their movement across membranes. This step is critical for determining substrate specificity and transport efficiency.
Translocation across membranes
In simple terms: The bound molecule is moved across the membrane through a transporter or pore.
Following binding, the substrate undergoes conformational changes in the transporter, leading to its translocation across the lipid bilayer. This can occur via facilitated diffusion, active transport, or channel-mediated movement. For example, ABCC4 (MRP4) actively transports nucleotide analogs out of cells, affecting drug resistance.
Intracellular trafficking and compartmentalization
In simple terms: Inside the cell, nucleotides are moved to specific compartments like the nucleus or mitochondria.
Once inside the cell, nucleobase-containing compounds are directed to various organelles. Mitochondrial transporters such as SLC25A family members mediate the uptake of nucleotides into mitochondria for energy metabolism and mtDNA synthesis. This compartmentalization ensures proper cellular function.
Metabolic integration and feedback
In simple terms: Transported molecules are used in metabolic pathways, and their levels feed back to regulate transport.
Transported nucleosides and nucleotides enter metabolic pathways, including nucleic acid synthesis and adenosine signaling. Feedback mechanisms, such as adenosine kinase (ADK) activity, regulate intracellular adenosine levels, which in turn affect transport rates. This integration maintains homeostasis.
Regulation by cellular signals
In simple terms: Cellular signals can increase or decrease transport activity.
Transport activity is regulated by various signals, including hypoxia, inflammation, and oncogenic pathways. For instance, in delayed cerebral ischemia, differential methylation of genes involved in nucleobase transport suggests epigenetic regulation. Such regulation allows cells to adapt to changing environments.
Key Genes Involved in GO:0015931 nucleobase-containing compound transport
The following genes encode transporters, channels, and enzymes that directly participate in or regulate nucleobase-containing compound transport.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC29A1 | Equilibrative nucleoside transporter 1; mediates adenosine and nucleoside uptake | Drug transport, cancer chemotherapy resistance |
| SLC28A1 | Concentrative nucleoside transporter 1; active transport of nucleosides | Nucleoside analog uptake in tumors |
| ABCC4 | ATP-binding cassette transporter; efflux of nucleotide analogs | Multidrug resistance, cancer |
| ADK | Adenosine kinase; phosphorylates adenosine, regulating intracellular levels | Neurological disorders, epilepsy |
| ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1; hydrolyzes extracellular nucleotides | Immune regulation, cancer |
| SLC25A | Mitochondrial carriers; transport nucleotides into mitochondria | Mitochondrial DNA synthesis, energy metabolism |
| DPYSL3 | Dihydropyrimidinase-like 3; involved in pyrimidine metabolism | Urothelial carcinoma prognosis |
| BLOC-1 | Biogenesis of lysosome-related organelles complex 1; affects adenosine metabolism | Hippocampal function, neurological disorders |
| Jatropha curcas genes | Drought-responsive genes including transporters | Plant stress adaptation |
| E. coli knockout genes | Genes affecting cytotoxicity and transport | Functional genomics, toxicology |
| Platelet genes | Tumor-educated platelet transcripts including transport genes | Gastrointestinal tumor diagnosis |
| Methylated genes | Differentially methylated transport-related genes | Delayed cerebral ischemia |
| Brain network genes | Genes involved in brain network stabilization | Childhood development |
| SLC29A2 | Equilibrative nucleoside transporter 2 | Nucleoside transport in various tissues |
| SLC28A2 | Concentrative nucleoside transporter 2 | Nucleoside drug uptake |
| SLC28A3 | Concentrative nucleoside transporter 3 | Nucleoside transport in liver and other tissues |
| NT5E | CD73; converts extracellular AMP to adenosine | Immune suppression, cancer |
How Is nucleobase-containing compound transport Regulated?
Nucleobase-containing compound transport is regulated at multiple levels, including transcriptional, post-transcriptional, and epigenetic mechanisms. For example, differential methylation of genes involved in this process has been observed in delayed cerebral ischemia, suggesting epigenetic control. Additionally, adenosine kinase (ADK) activity modulates intracellular adenosine levels, which can feedback on transport rates. In cancer, oncogenic signaling pathways can upregulate nucleoside transporters to support increased nucleotide demand. Hypoxia and inflammatory signals also influence transporter expression, allowing cells to adapt to stress.
nucleobase-containing compound transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC29A1 | Cancer drug resistance | Knockout in cancer cell lines; drug sensitivity assays |
| ABCC4 | Multidrug resistance | Overexpression and knockout in tumor cells |
| ADK | Epilepsy, neurological disorders | Knock-in mouse models; point mutations |
| DPYSL3 | Urothelial carcinoma | Knockdown and overexpression in urothelial cells |
| BLOC-1 | Hippocampal dysfunction | Knockout mouse; metabolic profiling |
Cancer and drug resistance
Altered expression of nucleoside transporters such as SLC29A1 and ABCC4 affects the uptake and efflux of chemotherapeutic nucleoside analogs, contributing to drug resistance in various cancers. Tumor-educated platelets show differential expression of transport-related genes, which can be used for gastrointestinal tumor diagnosis. DPYSL3, involved in pyrimidine metabolism, is upregulated in urothelial carcinoma and predicts poor prognosis.
Neurological disorders
Disrupted adenosine transport and metabolism in the brain are linked to delayed cerebral ischemia following subarachnoid hemorrhage, where differentially methylated genes include those involved in nucleobase transport. BLOC-1 deficiency causes alterations in adenosine metabolism in the postnatal mouse hippocampus, affecting neurological function. Brain network dynamics during childhood and adolescence may also involve transport-related genes.
Metabolic and other diseases
Nucleobase-containing compound transport is integral to cellular metabolism, and its dysfunction can contribute to metabolic disorders. For instance, E. coli knockout studies have identified genes affecting cytotoxicity and transport, providing insights into fundamental transport mechanisms. Plant studies under drought stress reveal global changes in gene expression, including transport-related genes, highlighting evolutionary conservation.
From nucleobase-containing compound transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC29A1 affect nucleoside uptake? | CRISPR knockout in HeLa or HEK293 cells |
| Does a point mutation in ABCC4 alter substrate specificity? | CRISPR point mutation knock-in |
| Can overexpression of ADK reduce adenosine levels? | CRISPR overexpression (CRISPRa) or lentiviral overexpression |
| Does tagging SLC28A1 with GFP affect localization? | Knock-in of fluorescent tag |
| Which genes are essential for nucleobase transport? | CRISPR library screening in E. coli or mammalian cells |
| Does DPYSL3 knockdown affect pyrimidine metabolism? | RNAi or CRISPR knockout in cancer cells |
How to Study the nucleobase-containing compound transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying transport genes in disease vs. normal |
| CRISPR knockout library screening | Gene essentiality and function | Discovering genes required for transport |
| DNA methylation profiling | Epigenetic modifications | Linking methylation to transport gene expression |
| Metabolomics | Levels of nucleobases and nucleotides | Assessing transport activity and metabolism |
| Fluorescent substrate uptake assays | Transport kinetics | Measuring transporter activity in live cells |
| Proteomics | Protein expression and interactions | Identifying transporter complexes |
| Imaging (live-cell) | Subcellular localization | Tracking transport dynamics |
| Network-based transcriptomic analysis | Gene co-expression networks | Identifying core genes in diseases |
Transcriptomic profiling
RNA-seq and microarray analyses can identify differentially expressed genes involved in nucleobase-containing compound transport. For example, global gene expression profiling in Jatropha curcas seedlings under drought stress revealed changes in transport-related genes. In clinical samples, transcriptomic analysis of tumor-educated platelets identified core genes for gastrointestinal tumor diagnosis.
Functional genomics and knockout libraries
Single-gene knockout libraries in E. coli or mammalian cells enable systematic assessment of gene function in transport processes. Guan et al. used a single-gene knockout library to assess cytotoxicity induced by 2,2-bis(bromomethyl)-1,3-propanediol, identifying genes involved in transport and metabolism.
Methylation analysis
DNA methylation profiling can reveal epigenetic regulation of transport genes. In patients with delayed cerebral ischemia, differentially methylated genes and pathways were identified, including those related to nucleobase transport.
Metabolic and flux analysis
Metabolomics and flux analysis measure the movement and utilization of nucleobases and nucleotides. BLOC-1 deficiency in mouse hippocampus caused alterations in adenosine metabolism, which can be detected by metabolomic profiling.
How CRISPR Can Be Used to Study GO:0015931 nucleobase-containing compound transport
Knockout
CRISPR knockout of genes such as SLC29A1 or ABCC4 can abolish transport activity, allowing researchers to study their role in drug uptake and resistance. For example, knockout of SLC29A1 in cancer cells reduces nucleoside analog uptake, confirming its function.
Point Mutation
Introducing point mutations in transporter genes can reveal critical residues for substrate binding or translocation. For instance, point mutations in ABCC4 can alter its efflux capacity, providing insights into multidrug resistance mechanisms.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC28A1) enables real-time imaging of transport dynamics and localization. This approach can be used to study how mutations affect trafficking.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like ADK can increase transport or metabolic activity, helping to model diseases with elevated adenosine metabolism.
How EDITGENE Supports nucleobase-containing compound transport Research
Researchers studying nucleobase-containing compound transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for nucleobase-containing compound transport research.
Frequently Asked Questions About nucleobase-containing compound transport
What is GO:0015931 nucleobase-containing compound transport?
GO:0015931 is a Gene Ontology biological process term describing the directed movement of nucleobases, nucleosides, nucleotides, and nucleic acids into, out of, or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in nucleobase-containing compound transport?
Key genes include SLC29A1, SLC28A1, ABCC4, ADK, ENTPD1, and SLC25A family members, which encode transporters and enzymes that mediate or regulate the movement of nucleobases and nucleotides [1,5].
How is nucleobase-containing compound transport regulated?
It is regulated at transcriptional, post-transcriptional, and epigenetic levels. For example, differential methylation of transport genes occurs in delayed cerebral ischemia, and adenosine kinase activity modulates intracellular adenosine levels [4,5].
Why is nucleobase-containing compound transport important in cancer?
Altered transport affects the uptake and efflux of nucleoside analog drugs, influencing chemotherapy resistance. Tumor-educated platelets show differential expression of transport genes, which can aid in gastrointestinal tumor diagnosis.
What diseases are associated with defects in nucleobase-containing compound transport?
Diseases include cancer, delayed cerebral ischemia, neurological disorders, and metabolic diseases. For instance, BLOC-1 deficiency alters adenosine metabolism in the hippocampus [4,5].
How can CRISPR be used to study nucleobase-containing compound transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to interrogate gene function, substrate specificity, and disease relevance. Library screening can identify essential transport genes.
What methods are used to study nucleobase-containing compound transport?
Common methods include RNA-seq, DNA methylation profiling, metabolomics, fluorescent substrate uptake assays, proteomics, and CRISPR library screening [1,4,5,7].
What is the role of SLC29A1 in nucleobase-containing compound transport?
SLC29A1 encodes equilibrative nucleoside transporter 1, which mediates the uptake of adenosine and nucleoside analogs, affecting drug sensitivity and cellular signaling.
How does adenosine transport affect brain function?
Adenosine transport regulates extracellular adenosine levels, which modulate neuronal activity and are implicated in delayed cerebral ischemia and hippocampal dysfunction [4,5].
Can EDITGENE help with CRISPR models for transport genes?
Yes, EDITGENE provides knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to nucleobase-containing compound transport research.
Conclusion
Nucleobase-containing compound transport (GO:0015931) is a critical biological process that ensures the proper distribution of nucleobases, nucleosides, nucleotides, and nucleic acids for cellular function. Its dysregulation is linked to cancer, neurological disorders, and metabolic diseases, making it a key area of research. Advances in CRISPR-based models and functional genomics are enabling precise interrogation of the genes and mechanisms involved, offering new opportunities for therapeutic development. EDITGENE stands ready to support these efforts with comprehensive CRISPR services.
References
- 1. Jiang Y et al.. 2023. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.. Platelets 34(1):2212071 PMID: 37212262
- 2. Lei T et al.. 2022. Progressive Stabilization of Brain Network Dynamics during Childhood and Adolescence.. Cereb Cortex 32(5):1024-1039 PMID: 34378030
- 3. Liang PI et al.. 2023. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.. BMC Cancer 23(1):599 PMID: 37380971
- 4. Kim BJ et al.. 2022. Identification of Differentially-Methylated Genes and Pathways in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage.. J Korean Neurosurg Soc 65(1):4-12 PMID: 34320780
- 5. van Liempd SM et al.. 2017. BLOC-1 deficiency causes alterations in amino acid profile and in phospholipid and adenosine metabolism in the postnatal mouse hippocampus.. Sci Rep 7(1):5231 PMID: 28701731
- 6. Zhang C et al.. 2015. Global analysis of gene expression profiles in physic nut (Jatropha curcas L.) seedlings exposed to drought stress.. BMC Plant Biol 15:17 PMID: 25604012
- 7. Guan M et al.. 2017. Functional genomic assessment of 2, 2-bis (bromomethyl)-1, 3-propanediol induced cytotoxicity in a single-gene knockout library of E. coli.. Chemosphere 185:582-588 PMID: 28719877
